| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-09-07 |
4 |
GA |
$0.00 |
$0 |
D/D |
26,468 |
1,699,550 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-09-27 |
4 |
AS |
$111.96 |
$7,542,011 |
D/D |
(67,000) |
1,632,550 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-09-28 |
4 |
OE |
$4.03 |
$766,305 |
D/D |
125,384 |
1,681,834 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-09-28 |
4 |
AS |
$111.44 |
$8,480,584 |
D/D |
(76,100) |
1,672,114 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-10-01 |
4 |
OE |
$4.03 |
$72,822 |
D/D |
18,070 |
1,699,904 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-10-01 |
4 |
AS |
$115.26 |
$2,082,946 |
D/D |
(18,070) |
1,681,834 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-10-31 |
4 |
OE |
$4.03 |
$21,419 |
D/D |
5,315 |
1,687,149 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-10-31 |
4 |
AS |
$94.98 |
$758,237 |
D/D |
(7,982) |
1,679,167 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-11-28 |
4 |
AS |
$94.96 |
$4,607,334 |
D/D |
(48,515) |
1,644,167 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-11-28 |
4 |
OE |
$4.03 |
$54,465 |
D/D |
13,515 |
1,692,682 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-12-18 |
4 |
AS |
$95.68 |
$3,348,800 |
D/D |
(35,000) |
1,609,167 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-01-02 |
4 |
AS |
$99.93 |
$779,754 |
D/D |
(7,803) |
1,601,364 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-01-09 |
4 |
AS |
$99.96 |
$2,718,612 |
D/D |
(27,197) |
1,574,167 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-01-15 |
4 |
AS |
$98.58 |
$3,450,405 |
D/D |
(35,000) |
1,539,167 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-01-28 |
4 |
S |
$94.50 |
$241,920 |
D/D |
(2,560) |
1,536,607 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-01-29 |
4 |
S |
$94.32 |
$252,966 |
D/D |
(2,682) |
1,533,925 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-02-04 |
4 |
S |
$95.86 |
$1,143,718 |
D/D |
(11,880) |
1,522,045 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
16,500 |
1,538,545 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-04-01 |
4 |
AS |
$95.00 |
$3,325,000 |
D/D |
(35,000) |
1,503,545 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-04-02 |
4 |
AS |
$99.97 |
$829,751 |
D/D |
(8,300) |
1,495,245 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-04-10 |
4 |
AS |
$100.24 |
$2,676,408 |
D/D |
(26,700) |
1,468,545 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-04-17 |
4 |
AS |
$95.04 |
$3,326,400 |
D/D |
(35,000) |
1,433,545 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-05-10 |
4 |
AS |
$100.12 |
$3,504,200 |
D/D |
(35,000) |
1,398,545 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-05-13 |
4 |
AS |
$104.94 |
$652,727 |
D/D |
(6,220) |
1,392,325 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-05-14 |
4 |
AS |
$105.38 |
$3,289,759 |
D/D |
(31,113) |
1,361,212 |
0 |
- |
|
283 Records found
|
|
Page 6 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
